In summary, our data demonstrates that MET protects against BLM-induced PF of mice in vivo and attenuates TGF-β1-induced fibroblasts activation in vitro by targeting S100A4 via AMPK-STAT3 axis (Figure 7). This evidence concerns the gene STAT3 and Bloom syndrome.